These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2946837)

  • 1. Class II major histocompatibility complex and organ specific autoimmunity in man.
    Foulis AK
    J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes.
    Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF
    Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
    Foulis AK
    J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cell MHC class II antigens: a perspective on the aetiology of autoimmune thyroid disease.
    Davies TF; Roman SH; Mackenzie WA; Goldsmith N; Dower SM; Piccinini LA
    Acta Endocrinol Suppl (Copenh); 1987; 281():13-20. PubMed ID: 3303789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
    Walden P; Nagy ZA; Klein J
    J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC.
    Sugihara S; Fujiwara H; Niimi H; Shearer GM
    J Immunol; 1995 Aug; 155(3):1619-28. PubMed ID: 7543527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA transgenic mice as models of human autoimmune diseases.
    Das P; Abraham R; David C
    Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of T-cell subpopulations. Pathophysiological concept and significance for clinical medicine].
    Pichler WJ; Emmendörffer A; Peter HH; Deicher HR; Fontana A; de Weck AL
    Schweiz Med Wochenschr; 1985 Apr; 115(16):534-50. PubMed ID: 3159084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
    Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
    Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathyroidal MHC class II antigen expression and thyroid autoimmunity.
    Davies TF; Piccinini LA
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):247-68. PubMed ID: 3319584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-dependent destruction of thyroid isografts exposed to IFN-gamma.
    Frohman M; Francfort JW; Cowing C
    J Immunol; 1991 Apr; 146(7):2227-34. PubMed ID: 1900881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
    Muixí L; Alvarez I; Jaraquemada D
    Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen specific immune response potential and HLA typing of Israeli patients with thyroid autoimmune diseases (TAD).
    Shalev Y; Bentwich Z; Katz D; Brautbar C; Mozes E
    Clin Exp Immunol; 1986 May; 64(2):255-60. PubMed ID: 2427266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II MHC expression in normal adrenal cortex and cortical cells in autoimmune Addison's disease.
    Jackson R; McNicol AM; Farquharson M; Foulis AK
    J Pathol; 1988 Jun; 155(2):113-20. PubMed ID: 3292733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.